[ad_1]
OrganiGram Holdings Inc.’s stock was up 5.6% in premarket trading Wednesday after the Canadian cannabis producer reported better-than-expected revenue.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...